User profiles for Suad MA. Hannawi

Suad Hannawi

Consultant of Rheumatology
Verified email at ausdoctors.net
Cited by 1490

[HTML][HTML] Cardiovascular risk in rheumatoid arthritis: Literature review

SMA Hannawi, H Hannawi, I Al Salmi - Oman Medical Journal, 2021 - ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) is the most common inflammatory arthritis disease with a worldwide
prevalence of 1–3%. RA patients are at higher risk of atherosclerosis than their matched …

[HTML][HTML] Subclinical atherosclerosis in rheumatoid arthritis patients of the Gulf Cooperated Council

SMA Hannawi, H Hannawi, F Alokaily… - Saudi Medical …, 2020 - ncbi.nlm.nih.gov
Objectives: To assess the existence of subclinical atherosclerosis in the Gulf Cooperation
Council (GCC) rheumatoid arthritis (RA) patients in comparison to age, gender and …

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies

A Balgos, S Hannawi, WL Chen, A Abuquta… - Expert Review of …, 2024 - Taylor & Francis
Background Recombinant protein vaccines are vital for broad protection against SARS-CoV-2
variants. This study assessed ReCOV as a booster in two Phase 2 trials. Research design …

Role of chemokines and chemokine receptors in rheumatoid arthritis

NM Elemam, S Hannawi… - ImmunoTargets and …, 2020 - Taylor & Francis
Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases and a prototypic
inflammatory disease, affecting the small joints of the hands and feet. Chemokines and …

Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation

S Hannawi, B Haluska, TH Marwick… - Arthritis research & …, 2007 - Springer
Rheumatoid arthritis (RA) patients have increased mortality and morbidity as a result of
cardiovascular and cerebrovascular disease. What is not clear, however, is either how early …

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

S Hannawi, L Saf Eldin, A Abuquta, A Alamadi… - Nature …, 2023 - nature.com
… DI and MA contributed to the revision and interpretation of data for this work. SX, JL, DL,
AAHB, and YC contributed to the medical management, protocol writing, statistical analysis, and …

Systemic lupus erythematosus: symptoms and signs at initial presentations

…, F Al Ismaili, A Hola, S Hannawi - Anti-Inflammatory & …, 2019 - ingentaconnect.com
… lupus erythematosus (SLE) is an autoimmune multisystem inflammatory condition that
causes microvascular inflammation with the production of various auto-antibodies that play a ma

Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: A randomized, double …

S Hannawi, LS Eldin, A Abuquta, A Alamadi… - …, 2023 - thelancet.com
Suad Hannawi was the study site principal investigator, responsible for the supervision of the
study, … Suad Hannawi and Dr. Liangzhi Xie verified the underlying data. All authors critically …

Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis

S Hannawi, TH Marwick, R Thomas - Arthritis research & therapy, 2009 - Springer
Introduction Patients with recent-onset rheumatoid arthritis (RA) have impaired brachial artery
endothelial function compared with controls matched for age, sex and cardiovascular risk …

Cells of the synovium in rheumatoid arthritis. Dendritic cells

V Lutzky, S Hannawi, R Thomas - Arthritis research & therapy, 2007 - Springer
Dendritic cells are the major antigen-presenting and antigen-priming cells of the immune
system. We review the antigen-presenting and proinflammatory roles played by dendritic cells …